GenSight participated to Phacilitate Cell&Gene Therapy in Washington DC.
On Monday January 25, 2016, Jean Philippe Combal, COO at GenSight, gave a talk on ” Retinal Ganglion Cells Targeting with LHON & Optogenetics for RP : Translational development up to Pivotal trials ” at 3.25 pm within the track ” CELL & GENE THERAPY CLINICAL UPDATES: OPHTHALMOLOGY “.